Organon & Co.
OGN · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $1,602,000 | $1,594,000 | $1,513,000 | $1,592,000 |
| % Growth | 0.5% | 5.4% | -5% | – |
| Cost of Goods Sold | $745,000 | $720,000 | $672,000 | $696,000 |
| Gross Profit | $857,000 | $874,000 | $841,000 | $896,000 |
| % Margin | 53.5% | 54.8% | 55.6% | 56.3% |
| R&D Expenses | $84,000 | $95,000 | $96,000 | $130,000 |
| G&A Expenses | $0 | $0 | $0 | $262,000 |
| SG&A Expenses | $415,000 | $453,000 | $420,000 | $470,000 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $206,000 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $499,000 | $548,000 | $516,000 | $600,000 |
| Operating Income | $358,000 | $326,000 | $325,000 | $296,000 |
| % Margin | 22.3% | 20.5% | 21.5% | 18.6% |
| Other Income/Exp. Net | -$115,000 | -$97,000 | -$224,000 | -$167,000 |
| Pre-Tax Income | $243,000 | $229,000 | $101,000 | $129,000 |
| Tax Expense | $83,000 | $84,000 | $14,000 | $20,000 |
| Net Income | $160,000 | $145,000 | $87,000 | $109,000 |
| % Margin | 10% | 9.1% | 5.8% | 6.8% |
| EPS | 0.62 | 0.56 | 0.34 | 0.42 |
| % Growth | 10.7% | 64.7% | -19% | – |
| EPS Diluted | 0.61 | 0.56 | 0.33 | 0.42 |
| Weighted Avg Shares Out | 259,975 | 259,939 | 257,862 | 257,690 |
| Weighted Avg Shares Out Dil | 260,653 | 260,156 | 261,001 | 259,878 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $128,000 | $132,000 | $124,000 | $132,000 |
| Depreciation & Amortization | $89,000 | $89,000 | $100,000 | $76,000 |
| EBITDA | $460,000 | $449,000 | $325,000 | $341,000 |
| % Margin | 28.7% | 28.2% | 21.5% | 21.4% |